AzPA Pharmacy Flash
Mar. 11, 2015

NEW AzPA Women's Reproductive Health Certificate Program
We are excited to unveil our new certificate program April 25 in Phoenix. Topics will focus on the management and care of commonly encountered female reproductive issues such as contraception, menstrual disorders, infertility and pregnancy. Register at! Bonus: Participating pharmacists will receive $50 promo code to use toward Annual Convention registration. Use this flyer to share with your colleagues!More

2015 AzPA Annual Convention OPEN FOR REGISTRATION
Join us for three days of continuing education and networking June 26-28 at the Westin La Paloma Resort & Spa in Tucson. Choose to attend the full conference, or specify a single day. AzPA members receive a reduced rate. Not a member? Don’t worry. Your three-day convention rate includes one year AzPA membership. Register now at More

Novel anticoagulants target cancer patients with CVC
By Dr. Afsaneh Motamed-Khorasani
Anticoagulants have been traditionally used to treat venous thromboembolism, which is a major healthcare problem. Sometimes, there is a need in cancer patients to have a central venous catheter, which could in turn increase the chance of thrombosis. Therefore, the potential for the use of parenteral anticoagulants is being studied in ambulatory cancer patients undergoing chemotherapy, radiation or hormonal therapies that otherwise lack the prophylactic or therapeutic indication for the use of these category of drugs.More

Influenza hits older adults hard this season
The CDC reports that influenza activity in the United States was elevated as of Feb. 21, with further activity expected for several more weeks. Influenza A viruses have predominated, and older adults have been the hardest hit. Adults aged 65 and older also account for most of the deaths related to pneumonia and influenza, CDC said.More

Antidepressant medication may help lower stroke, coronary artery disease risks
Tech Times
Medications prescribed to treat depression could have an additional benefit for cardiovascular health by reducing risks of heart disease, researchers say.More

FDA launches drug shortages mobile app
Pharmacy Practice News
The FDA launched its first free mobile app specifically designed to speed public access to valuable information about drug shortages.More

Despite broad awareness, only half of doctors use prescription drug monitoring programs
Medical News Today
In a new survey, researchers at the Johns Hopkins Bloomberg School of Public Health found that physicians report relatively high awareness of state databases that track drug prescriptions but more than one-fifth indicated they were not aware of their state's program at all. More

Spider venom has strong painkiller potential
By Dorothy L. Tengler
Chronic pain is a serious health problem that affects more Americans than diabetes, heart disease and cancer combined. Part of the search for new pain-killing drugs has focused on the world's 45,000 species of spiders, many of which kill their prey with venoms that contain hundreds and even thousands of protein molecules, some of which block nerve activity. A new study in the British Journal of Pharmacology suggests that spider venom could lead to a more effective treatment for the millions suffering with chronic pain. More

COPD counseling takes center stage
Pharmacy Times
Leonard Nimoy's recent death from end-stage chronic obstructive pulmonary disease brought the condition into the spotlight, and may bring patients with questions to the pharmacy counter. More

FDA approves Zarxio, 1st US biosimilar
Pharmacy Practice News
The FDA recently approved Zarxio, the brand name of Sandoz's first biosimilar of filgrastim in this country. The approval includes all the same indications as the reference product Neupogen, made by Amgen.More